If you are wondering whether Johnson & Johnson shares still offer solid value after a strong run, this article will walk ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

In the latest trading session, Johnson & Johnson (JNJ) closed at $204.31, marking a -1.47% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.64%. Elsewhere, ...

Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...

The average one-year price target for Johnson & Johnson (NYSE:JNJ) has been revised to $204.02 / share. This is an increase of 10.96% from the prior estimate of $183.86 dated September 27, 2025. The ...

Johnson & Johnson (JNJ) is rumored to be in talks to acquire Protagonist Therapeutics (PTGX), following significant buyout speculation and a 30% PTGX stock surge. PTGX's value is underpinned by its ...

Johnson & Johnson (NYSE:JNJ) is included among the 15 Dividend Stocks that Outperform the S&P 500. Barclays lifted its price⁠ tar⁠g⁠et o⁠n Johnson & Johnson (NYSE:JNJ) to $197 from $176 on December 2 ...

Track the latest Congressional trades of Johnson & Johnson (JNJ) stock. See which US lawmakers are buying or selling Johnson & Johnson (JNJ), with dates, trade amounts, and disclosure details.

Johnson & Johnson (JNJ) has been quietly grinding higher, with shares up sharply over the past year even after a recent pullback. Investors are now asking whether this run still leaves meaningful ...